Literature DB >> 1864300

Side-effects of quinolones: comparisons between quinolones and other antibiotics.

S R Norrby1.   

Abstract

Fluoroquinolones are generally very safe antibiotics which do not cause serious or life-threatening adverse reactions. The most frequent side-effects are gastrointestinal reactions (nausea, dyspepsia, vomiting) and CNS reactions such as dizziness, insomnia and headache. Many of the more severe CNS reactions seem to be due to metabolic interaction with theophylline, especially when enoxacin is used. Of the potentially serious side-effects, photoxicity has been reported in varying frequencies with the different fluoroquinolones. Caution is necessary when this group of drugs, especially pefloxacin, is prescribed to patients who will have intensive exposure to UV light during treatment. The finding in juvenile animals of cartilage damage after administration of high doses have resulted in recommendations that fluoroquinolones should not be used in children. Carefully monitored studies should be performed in paediatric patients to assess whether there is a real risk of such adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864300     DOI: 10.1007/bf01967014

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Tolerance of intravenous ciprofloxacin.

Authors:  S B Thorsteinsson; V Rahm; T Bergan
Journal:  Scand J Infect Dis Suppl       Date:  1989

2.  Effect of new quinolones on drug-metabolizing enzyme system of rat hepatic microsomes.

Authors:  O Okazaki; T Kurata; H Tachizawa
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

3.  Convulsions and hyperglycaemia associated with nalidixic acid.

Authors:  A G Fraser; A D Harrower
Journal:  Br Med J       Date:  1977-12-10

4.  Phototoxic bullous eruptions due to nalidixic acid.

Authors:  D A Birkett; M Garretts; C J Stevenson
Journal:  Br J Dermatol       Date:  1969-05       Impact factor: 9.302

Review 5.  Photosensitivity due to drugs.

Authors:  J H Epstein; B U Wintroub
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 6.  Use of quinolones in pediatric patients.

Authors:  D Adam
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

7.  A critical evaluation of nalidixic acid in urinary-tract infections.

Authors:  A R Ronald; M Turck; R G Petersdorf
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

Review 8.  Adverse effects of the fluoroquinolones.

Authors:  H Halkin
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

9.  Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Authors:  A Tsuji; H Sato; Y Kume; I Tamai; E Okezaki; O Nagata; H Kato
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

  9 in total
  19 in total

1.  Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.

Authors:  G R Haines; M P Brown; R R Gronwall; K A Merritt
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Pharmacokinetics of difloxacin and its concentration in body fluids and endometrial tissues of mares after repeated intragastric administration.

Authors:  Aric R Adams; Gregory R Haines; Murray P Brown; Ronald Gronwall; Kelly Merritt
Journal:  Can J Vet Res       Date:  2005-07       Impact factor: 1.310

Review 3.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares.

Authors:  G R Haines; M P Brown; R R Gronwall; K A Merritt; L K Baltzley
Journal:  Can J Vet Res       Date:  2001-07       Impact factor: 1.310

Review 5.  Use of the quinolones in paediatrics.

Authors:  U B Schaad
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group.

Authors:  A Jardin; M Cesana
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 7.  Fluoroquinolones in paediatrics--1995.

Authors:  R Dagan
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.

Authors:  R Mattina; C E Cocuzza; M Cesana
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.

Authors:  W Klietmann; M Cesana; R K Rondel; J Focht
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Safety of trovafloxacin in treatment of lower respiratory tract infections.

Authors:  D Williams; S Hopkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.